NCT05006794
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05006794
Title Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ISR

Facility Status City State Zip Country Details
University of Colorado Hospital - Anschutz Cancer Pavilion (ACP) Aurora Colorado 80045 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
START Midwest Grand Rapids Michigan 49546 United States Details
Montefiore Medial Center - Montefiore Medical Park The Bronx New York 10467 United States Details
Novant Health Cancer Institute - Elizabeth (Breast Cancer) Charlotte North Carolina 28204 United States Details
Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
Oregon Health Oregon Health & Sciences University-Knight Cancer Institute Portland Oregon 97239 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
START San Antonio San Antonio Texas 78229 United States Details
START Mountain Region West Valley City Utah 84119 United States Details
Rambam Health Care Campus Haifa 31096 Israel Details
Hadassah Medical Center- Ein Kerem Jerusalem 91120 Israel Details
Tel-Aviv Sourasky Medical Center Tel Aviv 6423906 Israel Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field